Epineuron Technologies Inc.

8 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Oct 2038

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Sep 17, 2027
The maintenance fee for Systems and methods for delivering neuroregenerative therapy (US 10,589,089) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 10,589,089	Systems and methods for delivering neuroregenerative therapy In force Term ends Oct 24, 2038 · From the USPTO record	In force	Term ends Oct 24, 2038	From the USPTO record
US 11,247,045	Systems and Methods for Delivering Neuroregenerative Therapy In force Term ends Oct 24, 2038 · High confidence	In force	Term ends Oct 24, 2038	High confidence
US 12,318,608	Devices and methods for delivering neuroregenerative therapy In force Term ends Oct 24, 2038 · From the USPTO record	In force	Term ends Oct 24, 2038	From the USPTO record
US 12,616,832	Systems and Methods for Delivering Neuroregenerative Therapy In force Term ends Oct 24, 2038 · High confidence	In force	Term ends Oct 24, 2038	High confidence
US 11,247,044	Devices for delivering neuroregenerative therapy In force Term ends Aug 24, 2039 · From the USPTO record	In force	Term ends Aug 24, 2039	From the USPTO record
US 11,247,043	Electrode interface devices for delivery of neuroregenerative therapy In force Term ends Sep 30, 2040 · From the USPTO record	In force	Term ends Sep 30, 2040	From the USPTO record
US 11,364,381	Methods for delivering neuroregenerative therapy and reducing post-operative and chronic pain In force Ends no later than Sep 30, 2040 · From the USPTO record	In force	Ends no later than Sep 30, 2040	From the USPTO record
US 12,611,538	Electrode Interface Devices for Delivery of Neuroregenerative Therapy In force Term ends Sep 30, 2040 · Medium confidence	In force	Term ends Sep 30, 2040	Medium confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 no status recorded

List them